56th Annual Meeting
Tentative Program Schedule
Please note that this schedule is subject to change. The Program Book distributed at the Annual Meeting will have final information on dates, times, and speakers for each presentation.
Home | Search | Browse by Day or Program | Author Index


Symposium 13 (open)
Special Pharmacotherapy Considerations in the Treatment of Pediatric ADHD

Thursday, October 30, 2008: 8:00 AM-11:00 AM
Chicago VII
Level 4
Sheraton Chicago Hotel & Towers
Chair:
Timothy Wilens, M.D.
Discussant:
Laurence L. Greenhill, M.D.
 
13.1
A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children with ADHD
Christopher J. Kratochvil, M.D. University of Nebraska Medical Center, Omaha, NE
 
13.2
Plasma Methylphenidate (MPH) Levels in Children Treated with High-Dose OROS MPH
Jonathan R. Stevens, M.D., M.P.H. Massachusetts General Hospital, Boston, MA
 
13.3
Common and Unique Effects of Methylphenidate and Atomoxetine in the Treatment of ADHD
Jeffrey Newcorn, M.D. Mount Sinai School of Medicine, New York, NY
 
13.4
Combined Atomoxetine and OROS Methylphenidate in Children with ADHD
Timothy Wilens, M.D. Massachusetts General Hospital, Boston, MA
See more of: Symposium
<< Previous Session | Next Session >>